Cargando…
Protective effect of inhaled corticosteroid on children with asthma with Mycoplasma pneumoniae pneumonia
BACKGROUND: The aim of this study was to determine the differences in the characteristics of Mycoplasma pneumoniae pneumonia (MPP) in children with and without asthma and in children with asthma with and without inhaled corticosteroid (ICS) therapy in order to determine the risk factors for asthma e...
Autores principales: | Wei, Bing, Dang, Yan-Hong, Liu, Xiang-Ping, Li, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452955/ https://www.ncbi.nlm.nih.gov/pubmed/36090550 http://dx.doi.org/10.3389/fped.2022.908857 |
Ejemplares similares
-
Low-Dose Corticosteroid Treatment in Children With Mycoplasma pneumoniae Pneumonia: A Retrospective Cohort Study
por: Zhang, Liya, et al.
Publicado: (2020) -
Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019) -
Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children
por: Zhang, Tongqiang, et al.
Publicado: (2021) -
D-dimer: The Risk Factor of Children's Severe Mycoplasma Pneumoniae Pneumonia
por: Qiu, Juan, et al.
Publicado: (2022) -
Development of a Nomogram for Predicting Refractory Mycoplasma pneumoniae Pneumonia in Children
por: Shen, Fangfang, et al.
Publicado: (2022)